Announcement • Apr 22
Sanbo Hospital Management Group Limited announced that it expects to receive CNY 300 million in funding Sanbo Hospital Management Group Limited has announced to issue Private Placement of not more than 30% of total share capital A Shares at a price of not less than 80% of the average price in the 20 trading days before the pricing reference date for gross proceeds of not more than CNY 300,000,000 on April 20, 2026. The transaction includes not more than 35 investors participation. The transaction has been approved by Board of directors at 18th Meeting of the 3rd Directorate and is subject to approval of company shareholders. All the securities issued pursuant to the offering are subject to hold period of six months from closing date. Reported Earnings • Apr 22
Full year 2025 earnings released: EPS: CN¥0.41 (vs CN¥0.51 in FY 2024) Full year 2025 results: EPS: CN¥0.41 (down from CN¥0.51 in FY 2024). Revenue: CN¥1.73b (up 21% from FY 2024). Net income: CN¥84.2m (down 20% from FY 2024). Profit margin: 4.9% (down from 7.3% in FY 2024). The decrease in margin was driven by higher expenses. Announcement • Apr 22
Sanbo Hospital Management Group Limited, Annual General Meeting, May 22, 2026 Sanbo Hospital Management Group Limited, Annual General Meeting, May 22, 2026, at 14:00 China Standard Time. Location: 3F, No. 69, Banjing Road, Haidian District, Beijing China Announcement • Mar 31
Sanbo Hospital Management Group Limited to Report Q1, 2026 Results on Apr 29, 2026 Sanbo Hospital Management Group Limited announced that they will report Q1, 2026 results on Apr 29, 2026 New Risk • Jan 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (34% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Profit margins are more than 30% lower than last year (5.1% net profit margin). Announcement • Dec 31
Sanbo Hospital Management Group Limited to Report Fiscal Year 2025 Results on Apr 22, 2026 Sanbo Hospital Management Group Limited announced that they will report fiscal year 2025 results on Apr 22, 2026 Reported Earnings • Oct 28
Third quarter 2025 earnings released: EPS: CN¥0.069 (vs CN¥0.19 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.069 (down from CN¥0.19 in 3Q 2024). Revenue: CN¥446.0m (up 26% from 3Q 2024). Net income: CN¥13.9m (down 63% from 3Q 2024). Profit margin: 3.1% (down from 11% in 3Q 2024). The decrease in margin was driven by higher expenses. Announcement • Sep 30
Sanbo Hospital Management Group Limited to Report Q3, 2025 Results on Oct 28, 2025 Sanbo Hospital Management Group Limited announced that they will report Q3, 2025 results on Oct 28, 2025 New Risk • Sep 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (36% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change). Reported Earnings • Aug 28
Second quarter 2025 earnings released: EPS: CN¥0.15 (vs CN¥0.16 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.15 (down from CN¥0.16 in 2Q 2024). Revenue: CN¥433.8m (up 18% from 2Q 2024). Net income: CN¥31.4m (down 5.4% from 2Q 2024). Profit margin: 7.2% (down from 9.0% in 2Q 2024). The decrease in margin was driven by higher expenses. Declared Dividend • Jul 06
Dividend of CN¥0.15 announced Shareholders will receive a dividend of CN¥0.15. Ex-date: 9th July 2025 Payment date: 9th July 2025 Dividend yield will be 0.3%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is covered by earnings (25% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years. Earnings per share has grown by 8.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. New Risk • Jul 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (36% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change). Announcement • Jul 02
Sanbo Hospital Management Group Limited to Report First Half, 2025 Results on Aug 27, 2025 Sanbo Hospital Management Group Limited announced that they will report first half, 2025 results on Aug 27, 2025 Announcement • May 22
Sanbo Hospital Management Group Limited Approves Final Cash Dividend for 2024 Sanbo Hospital Management Group Limited at its AGM held on May 16, 2025 approved the profit distribution proposal for 2024 as follows: Final cash dividend per 10 shares (tax included) of CNY 1.48000000. Announcement • Apr 19
Sanbo Hospital Management Group Limited Proposes Final Cash Dividend for 2024 Sanbo Hospital Management Group Limited announced on 18 April 2025 the profit distribution proposal for 2024 as follows: Final cash dividend per 10 shares (tax included) of CNY 1.48000000. Announcement • Apr 18
Sanbo Hospital Management Group Limited, Annual General Meeting, May 16, 2025 Sanbo Hospital Management Group Limited, Annual General Meeting, May 16, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (25% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change). Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥40.57, the stock trades at a trailing P/E ratio of 75.1x. Average trailing P/E is 32x in the Healthcare industry in China. Total loss to shareholders of 10% over the past year. Announcement • Mar 31
Sanbo Hospital Management Group Limited to Report Q1, 2025 Results on Apr 26, 2025 Sanbo Hospital Management Group Limited announced that they will report Q1, 2025 results on Apr 26, 2025 Announcement • Dec 31
Sanbo Hospital Management Group Limited to Report Fiscal Year 2024 Results on Apr 18, 2025 Sanbo Hospital Management Group Limited announced that they will report fiscal year 2024 results on Apr 18, 2025 Reported Earnings • Oct 26
Third quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.14 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.19 (up from CN¥0.14 in 3Q 2023). Revenue: CN¥354.9m (up 11% from 3Q 2023). Net income: CN¥37.9m (up 32% from 3Q 2023). Profit margin: 11% (up from 8.9% in 3Q 2023). The increase in margin was driven by higher revenue. Announcement • Sep 30
Sanbo Hospital Management Group Limited to Report Q3, 2024 Results on Oct 26, 2024 Sanbo Hospital Management Group Limited announced that they will report Q3, 2024 results on Oct 26, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥36.33, the stock trades at a trailing P/E ratio of 73.9x. Average trailing P/E is 30x in the Healthcare industry in China. Total loss to shareholders of 28% over the past year. Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.11 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.16 (up from CN¥0.11 in 2Q 2023). Revenue: CN¥366.9m (up 12% from 2Q 2023). Net income: CN¥33.2m (up 76% from 2Q 2023). Profit margin: 9.0% (up from 5.8% in 2Q 2023). The increase in margin was driven by higher revenue. Announcement • Jun 29
Sanbo Hospital Management Group Limited to Report First Half, 2024 Results on Aug 28, 2024 Sanbo Hospital Management Group Limited announced that they will report first half, 2024 results on Aug 28, 2024 Announcement • May 29
Sanbo Hospital Management Group Limited, Annual General Meeting, Jun 17, 2024 Sanbo Hospital Management Group Limited, Annual General Meeting, Jun 17, 2024, at 13:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Reported Earnings • Apr 20
Full year 2023 earnings released: EPS: CN¥0.54 (vs CN¥0.53 in FY 2022) Full year 2023 results: EPS: CN¥0.54 (up from CN¥0.53 in FY 2022). Revenue: CN¥1.31b (up 23% from FY 2022). Net income: CN¥78.2m (up 24% from FY 2022). Profit margin: 6.0% (up from 5.9% in FY 2022). The increase in margin was driven by higher revenue. Announcement • Mar 30
Sanbo Hospital Management Group Limited to Report Q1, 2024 Results on Apr 27, 2024 Sanbo Hospital Management Group Limited announced that they will report Q1, 2024 results on Apr 27, 2024 New Risk • Jan 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Announcement • Dec 29
Sanbo Hospital Management Group Limited to Report Fiscal Year 2023 Results on Apr 19, 2024 Sanbo Hospital Management Group Limited announced that they will report fiscal year 2023 results on Apr 19, 2024 Announcement • Sep 23
Sanbo Hospital Management Group Limited Approves Management Elections Sanbo Hospital Management Group Limited at its Extraordinary General Meeting held on 20 September 2023 approved the election of Cai Binbin and Xu Xiangying as non-independent director. The company approved the election of Zhang Dan, JIANGNAN CAI and Zhang Yaping as independent director. The company approved the election of Jiang Huimin and Yan Shilei as non-employee supervisor. Reported Earnings • Aug 28
Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.15 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.14. Revenue: CN¥327.8m (up 23% from 2Q 2022). Net income: CN¥18.9m (up 7.3% from 2Q 2022). Profit margin: 5.8% (down from 6.6% in 2Q 2022). The decrease in margin was driven by higher expenses. Announcement • May 30
Sanbo Hospital Management Group Limited, Annual General Meeting, Jun 16, 2023 Sanbo Hospital Management Group Limited, Annual General Meeting, Jun 16, 2023, at 14:30 China Standard Time. Agenda: To consider the 2022 work report of the board of directors; to consider the 2022 work report of the supervisory committee; to consider the 2022 annual accounts; to consider the 2022 profit distribution plan; to consider the reappointment of 2023 audit firm; to consider the cash management with idle raised funds; and to consider the amendments to the articles of association and handling the industrial and commercial registration amendment. Board Change • May 08
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.